Contrasting Preclinical Promise with Human Data The central challenge for clinicians is the stark contrast between the vast, overwhelmingly positive body of preclinical BPC-157 evidence and the near-total absence of published, peer-reviewed human clinical trials
Larger, more complex peptides or those with specific modifications often have built-in resistance to this degradation, giving them a much longer half life
J Agric Food Chem 63:78857895 Doenyas C (2018) Gut microbiota, inflammation, and probiotics on neural development in autism spectrum disorder
While anecdotes aren't data, the sheer volume of them is becoming impossible to ignore
doi: 10.3233/JAD-2010-122 101 NadeemA.AhmadS
They maintained a calm, confident demeanor throughout